Biomedicines | Free Full-Text | Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222
Risk adapted treatment recommendations in systemic AL amyloidosis.... | Download Scientific Diagram
COVID-19: time to flatten the infodemic curve – ScienceOpen
ΙΩΑΝΝΗΣ ΓΑΒΡΙΑΤΟΠΟΥΛΟΣ - Θήβα - Διάφορα - 11888.gr
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Pathogenesis of bone disease in multiple myeloma: from bench to bedside – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Ioannis V. Kostopoulos's 56 research works in Engineering and Economics
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library
Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop | Scientific Reports
PDF) The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
PDF) Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection | Efstathios Kastritis - Academia.edu
PDF) Predictive Factors for Neutralizing Antibody Levels Nine Months After Full Vaccination with BNT162b2: Results of a Machine Learning Analysis